ReviewRespiratory research2004
Application of microarray technology in pulmonary diseases.
Review in Respiratory research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.
- Meta-analysis of genetic programs between idiopathic pulmonary fibrosis and sarcoidosis.PloS one · 2013Pooled it
- Microarray analysis of differential gene expression profile in peripheral blood cells of patients with human essential hypertension.International journal of medical sciences · 2011Article
- Integrating genomic and clinical medicine: searching for susceptibility genes in complex lung diseases.Translational research : the journal of laboratory and clinical medicine · 2008Review
- Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?Respiratory research · 2006Review
- Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology.Mediators of inflammation · 2005Review
- Serum biomarkers in interstitial lung diseases.Respiratory research · 2005Review
- Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator.Respiratory research · 2005Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microarrays are a powerful tool that have multiple applications both in clinical and cell biology arenas of common lung diseases. To exemplify how this tool can be useful, in this review, we will provide an overview of the application of microarray technology in research relevant to common lung diseases and present some of the future perspectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.